Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman(Unknown), Sheila E. Taube(National Cancer Institute)
Cited by 1,027
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
|European Journal of Epidemiology|2016|3.1k
Evaluating non-randomised intervention studies
|Health Technology Assessment|2003|2.9k
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
|PLoS Medicine|2014|2k
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
|Journal of Clinical Epidemiology|2010|1.9k